Forte Biosciences Inc FBRX

Full chart Compare
Set alert

Price alert · FBRX

All alert types
76.99 USD 0.00 (+0.00%)

At closeAug 26, 2026, 4:00 PM EDT

21.03 -55.96 -72.68%

After hours · Aug 26, 4:00 PM ET

76.96 Day range 77.00
10.30 52-week range 77.20
YTD
+182.32%
1 year
+574.76%

Revenue & Expenses

Other Income → Expenses: $1.53MExpenses → Selling, General & Admin: $12.81MExpenses → Research & Development: $51.08MExpenses → Interest Expense: $2.93MExpenses → Income Tax: $1.70MGross Profit → Expenses: $18.04MRevenue → Gross Profit: $18.04MNet Loss → Expenses: $48.95MOther Income$1.53MGross Profit$18.04MNet Loss$48.95MExpenses$68.52MSelling, General & Admin$12.81MResearch & Development$51.08MInterest Expense$2.93MIncome Tax$1.70MRevenue$18.04M

Latest period ending Dec 31, 2025 · select a line to chart its full history

FBRX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-70.66M-36.60M-32.49M-13.90M-21.49M
-69.38M-35.48M-31.48M-13.88M-21.71M
-4.71-12.17-24.92-20.00-38.80
FBRX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
76.96M22.24M37.13M41.10M42.04M
82.78M61.56M38.98M42.00M43.31M
21.79M9.08M3.67M3.18M1.76M
60.99M52.48M35.31M38.82M41.55M
FBRX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-50.88M-30.75M-28.71M-8.19M-16.68M
36.23M-35.99M47.00K00
69.36M51.86M24.68M7.24M-44.00K
-116.00K-37.00K-88.00K00
54.71M-14.88M-3.98M-944.00K-16.72M